Patheon
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Patheon and buy or sell other stocks, ETFs, and their options commission-free!About PTHN
Patheon NV engages in the provision of pharmaceutical development and manufacturing services. It focuses on drug development, clinical trial logistics, and commercial manufacturing.
CEOJames C. Mullen, MBA
CEOJames C. Mullen, MBA
Employees—
Employees—
HeadquartersAmsterdam, Noord-Holland
HeadquartersAmsterdam, Noord-Holland
Founded2013
Founded2013
Employees—
Employees—
PTHN Key Statistics
Market cap5.08B
Market cap5.08B
Price-Earnings ratio46.64
Price-Earnings ratio46.64
Dividend yield—
Dividend yield—
Average volume177.41K
Average volume177.41K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$35.13
52 Week high$35.13
52 Week low$23.72
52 Week low$23.72
Stock Snapshot
With a market cap of 5.08B, Patheon(PTHN) trades at $34.98. The stock has a price-to-earnings ratio of 46.64.
Patheon(PTHN) stock opened on 2025-12-14 at —. The price climbed to — and dipped to —.
Patheon(PTHN) shares are trading with a volume of 0, against a daily average of 177.41K.
During the past year, Patheon(PTHN) stock moved between $23.72 at its lowest and $35.13 at its peak.
During the past year, Patheon(PTHN) stock moved between $23.72 at its lowest and $35.13 at its peak.